H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares traded.
H. Lundbeck A/S Stock Down 0.0 %
The stock’s 50-day moving average price is $22.00 and its 200-day moving average price is $22.00. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
See Also
- Five stocks we like better than H. Lundbeck A/S
- Technology Stocks Explained: Here’s What to Know About Tech
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.